POP-OUT | CLOSE

An Information Portal to 109822 Biological Macromolecular Structures

Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformational Mobility
Sequence Clustering and Redundancy Reduction Results
3JWD
Cluster # 1 Members. Sequence cutoff: 40% Cluster size: 3340 sequences | showing only first 1000 cluster members
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 4NZU 2 H 13PL light chain Fab 9606  
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
5 1MEX 1 L Fab 29G12 light chain 10090  
6 1MEX 2 H Fab 29G12 heavy chain 10090  
7 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090  
8 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090  
9 4BUH 1 A, B CLONE M0418 SCFV 9606  
10 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606  
11 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606  
12 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090  
13 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090  
14 2XZC 1 H FAB A.17 HEAVY CHAIN 9606  
15 2XZC 2 L FAB A.17 LIGHT CHAIN 9606  
16 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090  
17 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090  
18 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090  
19 1RUP 2 H immunoglobulin igg2a, light chain fab 10090  
20 1RUK 1 L immunoglobulin igg2a, light chain fab 10090  
21 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090  
22 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606  
23 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606  
24 2VXV 1 H HUMAN IGG ABT-325 9606  
25 2VXV 2 L HUMAN IGG ABT-325 9606  
26 4GXV 1 H, I Antibody 1F1, heavy chain 9606  
27 4GXV 2 L, M Antibody 1F1, light chain 9606  
28 2VXT 1 H MURINE IGG 125-2H 10090  
29 2VXT 3 L MURINE IGG 125-2H 10090  
30 1RUM 1 L immunoglobulin igg2a, light chain fab 10090  
31 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090  
32 2XZA 1 H FAB A.17 HEAVY CHAIN 9606  
33 2XZA 2 L FAB A.17 LIGHT CHAIN 9606  
34 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
35 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
36 4HPY 1 H CH59 Fab heavy chain 9606  
37 4HPY 2 L CH59 Fab light chain 9606  
38 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090  
39 3T65 2 A S25-2 FAB (IGG1K) light chain 10090  
40 4JG1 1 L Fab light chain 9606  
41 4JG1 2 H Fab heavy chain 9606  
42 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606  
43 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606  
44 4O5L 1 L Fab F045-092 light chain Fab F045-092 light chain 9606  
45 4O5L 2 H Fab F045-092 heavy chain Fab F045-092 heavy chain 9606  
46 3IFL 1 L 12A11 FAB antibody light chain 10090  
47 3IFL 2 H 12A11 FAB antibody heavy chain 10090  
48 3PP4 1 H GA101 Fab heavy chain 10090  
49 3PP4 2 L GA101 Fab light chain 10090  
50 3KDM 1 A, L Immunoglobulin light chain 9606  
51 3KDM 2 B, H Immunoglobulin heavy chain 9606  
52 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
53 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
54 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
55 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
56 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090  
57 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090  
58 4PTU 1 A Antibody pn132p2C05, light chain 9606  
59 4PTU 2 B Antibody pn132p2C05, heavy chain 9606  
60 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
61 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606  
62 3IFN 1 H 12A11 FAB antibody heavy chain 10090  
63 3IFN 2 L 12A11 FAB antibody light chain 10090  
64 4TOY 1 H 35O22 Fab Heavy chain 9606  
65 4TOY 2 L 35O22 Fab Light chain 9606  
66 3NPS 2 B S4 FAB HEAVY CHAIN 9606  
67 3NPS 3 C S4 FAB LIGHT CHAIN 9606  
68 1RUR 1 L immunoglobulin 13G5, light chain fab 10090  
69 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090  
70 4M5Y 1 H, I Fab 5J8 heavy chain 9606  
71 4M5Y 2 L, M Fab 5J8 light chain 9606  
72 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090  
73 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090  
74 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090  
75 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
76 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
77 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
78 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
79 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
80 3NTC 1 L Fab light chain 10090  
81 3NTC 2 H Fab heavy chain 10090  
82 4NWU 1 H APE1551 Ab Fab heavy chain 9606  
83 4NWU 2 L APE1551 Ab Fab light chain 9606  
84 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
85 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
86 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090  
87 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
88 4NZR 1 H PGT135 heavy chain Fab 9606  
89 4NZR 2 L PGT135 light chain Fab 9606  
90 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986  
91 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986  
92 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090  
93 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090  
94 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
95 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
96 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
97 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606  
98 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606  
99 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090  
100 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
101 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
102 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
103 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
104 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
105 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
106 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606  
107 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606  
108 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
109 3QQ9 2 D, H 101F HEAVY CHAIN 10090  
110 3OZ9 1 L Fab NC-1 kappa light chain 10090  
111 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090  
112 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606  
113 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
114 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606  
115 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606  
116 3G5Y 1 A 175 light chain 10090  
117 3G5Y 2 B 175 heavy chain 10090  
118 4N8C 1 H, I Heavy chain of monoclonal antibody 10090  
119 4N8C 2 L, M Light chain of monoclonal antibody 10090  
120 4HGW 1 A Antibody Fab fragment, light chain 10090  
121 4HGW 2 B Antibody Fab fragment, heavy chain 10090  
122 1NLB 1 L antibody 19D9D6 light chain 10090  
123 1NLB 2 H antibody 19D9D6 heavy chain 10090  
124 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
125 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
126 3VFG 1 L 3F8 Light Chain 10090  
127 3VFG 2 H 3F8 Heavy Chain 10090  
128 3QRG 1 L Fab light chain 9606  
129 3QRG 2 H Fab heavy chain Fd fragment 9606  
130 4LLY 2 B, D light chain Clambda 9606  
131 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
132 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090  
133 4K23 1 H anti-uPAR antibody, heavy chain 10090  
134 4K23 2 L anti-uPAR antibody, light chain 10090  
135 3NCJ 1 L Fab15 Mut8 light chain 9606  
136 3NCJ 2 H Fab15 Mut8 heavy chain 9606  
137 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
138 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
139 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090  
140 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090  
141 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090  
142 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090  
143 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
144 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
145 4M61 1 A, C Fab A52 light chain 10090  
146 4M61 2 B, D Fab A52 heavy chain 10090  
147 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
148 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
149 1UM5 1 L Antibody 21H3 L chain 10090  
150 1UM5 2 H Antibody 21H3 H chain 10090  
151 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
152 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
153 4NWT 1 L APE1531 Ab Fab light chain 9606  
154 4NWT 2 H APE1531 Ab Fab heavy chain 9606  
155 3WHX 1 A mAb Fab H fragment 10090  
156 3WHX 2 B mAb Fab L fragment 10090  
157 3NA9 1 L Fab15 light chain 9606  
158 3NA9 2 H Fab15 heavy chain 9606  
159 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
160 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
161 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
162 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
163 4LRI 1 A, B MSL-109 Light Chain 9606  
164 4LRI 2 C, P MSL-109 Heavy Chain 9606  
165 4JN2 1 A, L anti dabigatran Fab 10090  
166 4JN2 2 B, H anti dabigatran Fab 10090  
167 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090  
168 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090  
169 4JFZ 1 L Fab light chain 9606  
170 4JFZ 2 H Fab heavy chain 9606  
171 3WIF 1 A mAb Fab H fragment 10090  
172 3WIF 2 B mAb Fab L fragment 10090  
173 3MBX 1 L X836 LIGHT CHAIN 10090  
174 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090  
175 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606  
176 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606  
177 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
178 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606  
179 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090  
180 4RGO 2 H 14G8 heavy chain Fab 10090  
181 4RGO 3 L 14G8 light chain Fab 10090  
182 3NAA 1 L Fab15 Mut5 light chain 9606  
183 3NAA 2 H Fab15 Mut5 heavy chain 9606  
184 1Q0X 1 L Fab 9B1, light chain 10090  
185 1Q0X 2 H Fab 9B1, heavy chain 10090  
186 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844  
187 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844  
188 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090  
189 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
190 4WUK 1 H CH65 heavy chain 9606  
191 4WUK 2 L CH65 light chain 9606  
192 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
193 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
194 4HPO 1 H CH58 Fab heavy chain 9606  
195 4HPO 2 L CH58 Fab light chain 9606  
196 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090  
197 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090  
198 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606  
199 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606  
200 4PUB 1 H DX-2930 HEAVY CHAIN 9606  
201 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
202 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
203 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
204 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
205 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
206 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
207 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
208 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090  
209 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
210 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606  
211 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606  
212 3UYR 1 H antibody Fab heavy chain 10090  
213 3UYR 2 L antibody Fab light chain 10090  
214 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090  
215 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090  
216 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
217 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
218 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606  
219 3OAZ 2 K, L Fab 2G12, light chain 9606  
220 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090  
221 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
222 1ZAN 1 L Fab AD11 Light Chain 10116  
223 1ZAN 2 H Fab AD11 Heavy Chain 10116  
224 4N0Y 1 H IGH526 Heavy Chain 9606  
225 4N0Y 2 L IGH526 Light Chain 9606  
226 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
227 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
228 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090  
229 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090  
230 1RZF 1 L Fab E51 light chain 9606  
231 1RZF 2 H Fab E51 heavy chain 9606  
232 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544  
233 4KTE 2 L GE148 Light Chain Fab 9544  
234 4JG0 1 L Fab light chain 9606  
235 4JG0 2 H Fab heavy chain 9606  
236 4YGV 1 A, F aDabi-Fab2a heavy chain 9606  
237 4YGV 2 B, L aDabi-Fab2a light chain 9606  
238 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606  
239 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606  
240 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
241 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090  
242 4FQI 3 H antibody CR9114 heavy chain Fab 9606  
243 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606  
244 4JHA 1 H D25 antigen-binding fragment heavy chain 9606  
245 4JHA 2 L D25 light chain 9606  
246 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
247 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
248 4PTT 1 A Antibody pn132p2C05, light chain 9606  
249 4PTT 2 B Antibody pn132p2C05, heavy chain 9606  
250 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606  
251 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606  
252 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090  
253 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090  
254 4DGV 1 H HCV1 Heavy Chain Fab 9606  
255 4DGV 2 L HCV1 Light Chain 9606  
256 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
257 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
258 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606  
259 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606  
260 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090  
261 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090  
262 1YNL 1 L Ig gamma light chain 10090  
263 1YNL 2 H Ig gamma heavy chain 10090  
264 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090  
265 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
266 3UMT 1 A scFv heavy chain and light chain 10090  
267 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090  
268 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090  
269 4NUJ 1 A PGT152 light chain 9606  
270 4NUJ 2 B PGT152 heavy chain 9606  
271 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090  
272 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090  
273 1RUA 1 L immunoglobulin igg2a, light chain fab 10090  
274 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090  
275 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606  
276 3U2S 2 B, L PG9 light chain 9606  
277 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090  
278 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
279 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090  
280 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
281 4NUG 1 L PGT151 light chain 9606  
282 4NUG 2 H PGT151 heavy chain 9606  
283 3IU4 1 H chP3 Fab heavy chain 10090  
284 3IU4 2 L chP3 Fab light chain 10090  
285 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
286 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
287 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606  
288 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606  
289 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090  
290 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090  
291 1P7K 1 A, L antibody light chain FAB 10090  
292 1P7K 2 B, H antibody heavy chain FAB 10090  
293 3RVV 2 C 4C1 - light chain 10090  
294 3RVV 3 D 4C1 - heavy chain 10090  
295 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090  
296 3P0Y 2 H Fab DL11 heavy chain 9606  
297 3P0Y 3 L Fab DL11 light chain 9606  
298 4NPY 1 A, L germline PGT121 light chain Fab 9606  
299 4NPY 2 B, H germline PGT121 heavy chain Fab 9606  
300 2YPV 2 H FAB 12C1 10090  
301 2YPV 3 L FAB 12C1 10090  
302 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
303 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606  
304 4JY5 1 L PGT122 light chain Fab 9606  
305 4JY5 2 H PGT122 heavy chain Fab 9606  
306 3NAC 1 L Fab15 Mut7 light chain 9606  
307 3NAC 2 H Fab15 Mut7 heavy chain 9606  
308 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
309 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
310 1Q72 1 L Fab M82G2, Light chain 10090  
311 1Q72 2 H Fab M82G2, Heavy chain 10090  
312 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606  
313 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606  
314 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090  
315 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090  
316 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090  
317 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
318 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
319 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
320 4DGY 1 H HCV1 Heavy Chain Fab 9606  
321 4DGY 2 L HCV1 Light Chain 9606  
322 3T77 1 A S25-2 FAB (IGG1K) light chain 10090  
323 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090  
324 3MXW 2 L 5E1 light chain 9606  
325 3MXW 3 H 5E1 heavy chain 9606  
326 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
327 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630  
328 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
329 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606  
330 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090  
331 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090  
332 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090  
333 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090  
334 3C6S 1 A, C, E, G Fab F22-4 light chain 10090  
335 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090  
336 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090  
337 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090  
338 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090  
339 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090  
340 4JM4 1 H PGT 135 Heavy Chain Fab 9606  
341 4JM4 2 L PGT 135 Light Chain Fab 9606  
342 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
343 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
344 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090  
345 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090  
346 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
347 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
348 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090  
349 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090  
350 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
351 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606  
352 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
353 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
354 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
355 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
356 2FX7 1 L Fab 4E10 Light Chain 9606  
357 2FX7 2 H Fab 4E10 Heavy Chain 9606  
358 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606  
359 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606  
360 3WFH 1 A mAb Fab H fragment 10090  
361 3WFH 2 B mAb Fab L fragment 10090  
362 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913  
363 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913  
364 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
365 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
366 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
367 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090  
368 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
369 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
370 3RVW 2 C 4C1 - light chain 10090  
371 3RVW 3 D 4C1 - heavy chain 10090  
372 3D85 1 A FAB of antibody 7G10, light chain light chain 9606  
373 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606  
374 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090  
375 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090  
376 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090  
377 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090  
378 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
379 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
380 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090  
381 4JN1 2 L anti-dabigatran Fab1, light chain 10090  
382 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090  
383 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090  
384 4G5Z 1 H canakinumab antibody fragment heavy chain 9606  
385 4G5Z 2 L canakinumab antibody fragment light chain 9606  
386 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606  
387 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606  
388 2OK0 2 L Fab ED10 light chain 10090  
389 2OK0 3 H Fab ED10 heavy chain 10090  
390 3SOB 1 L antibody light chain 9606  
391 3SOB 3 H antibody heavy chain 9606  
392 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090  
393 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090  
394 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090  
395 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090  
396 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
397 2IH3 1 A FAB Heavy Chain 10090  
398 2IH3 2 B FAB Light Chain 10090  
399 4KQ3 1 L CNTO3186 light chain Fab 9606  
400 4KQ3 2 H CNTO3186 heavy chain Fab 9606  
401 4JFX 1 A, L Fab light chain 9606  
402 4JFX 2 B, H Fab heavy chain 9606  
403 3SGE 1 I, L Light Chain 10090  
404 3SGE 2 H, J Heavy Chain 10090  
405 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090  
406 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090  
407 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
408 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
409 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606  
410 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606  
411 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090  
412 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090  
413 1JGU 1 L Antibody Light Chain 10090  
414 1JGU 2 H Antibody Heavy Chain 10090  
415 4I77 1 H Lebrikizumab heavy chain Fab 9606  
416 4I77 2 L Lebrikizumab light chain Fab 9606  
417 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606  
418 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606  
419 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986  
420 4O4Y 2 H 2095-2 heavy chain 9986  
421 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
422 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
423 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
424 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
425 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031  
426 4GLR 3 I, K anti-ptau light chain light chain 9031  
427 4HJG 1 A Trastuzumab light chain 9606  
428 4HJG 2 B Trastuzumab heavy chain 9606  
429 4M43 1 L Fragment antigen-binding 523-11 light chain 10090  
430 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090  
431 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
432 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
433 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
434 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
435 3FN0 1 L Fab Z13e1 light chain 9606  
436 3FN0 2 H Fab Z13e1 heavy chain 9606  
437 4OSU 1 H SM5-1 Fab Heavy Chain 9606  
438 4OSU 2 L SM5-1 Fab Light Chain 9606  
439 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
440 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090  
441 1T2Q 1 L Fab NNA7 Heavy Chain 10090  
442 1T2Q 2 H Fab NNA7 Light Chain 10090  
443 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090  
444 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
445 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
446 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090  
447 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090  
448 3LEX 2 B, L 11f10 Antibody Light Chain 10090  
449 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
450 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606  
451 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
452 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
453 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606  
454 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606  
455 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
456 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
457 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
458 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
459 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090  
460 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090  
461 3S96 1 A, C 3B5H10 FAB heavy chain 10090  
462 3S96 2 B, D 3B5H10 FAB light chain 10090  
463 4LKX 1 A Fab fragment heavy chain 9606  
464 4LKX 2 B Fab fragment light chain 9606  
465 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
466 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
467 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606  
468 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606  
469 4FQ2 1 H Fab heavy chain 9606  
470 4FQ2 2 L Fab light chain 9606  
471 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090  
472 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090  
473 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090  
474 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090  
475 2A77 1 L Immunoglobulin Light Chain 10090  
476 2A77 2 H Immunoglobulin Heavy Chain 10090  
477 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606  
478 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606  
479 3GO1 1 L Fab 268-D, light chain 9606  
480 3GO1 2 H Fab 268-D, heavy chain 9606  
481 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090  
482 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090  
483 3QWO 1 B, L motavizumab light chain 10090  
484 3QWO 2 A, H motavizumab heavy chain 10090  
485 3CVI 1 H 25-D1.16 Heavy chain 10090  
486 3CVI 2 L 25-D1.16 Light chain 10090  
487 1PZ5 1 A Light chain of Fab (SYA/J6) 10090  
488 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090  
489 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116  
490 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116  
491 4IOI 1 A Trastuzumab light chain 9606  
492 4IOI 2 B Trastuzumab heavy chain 9606  
493 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
494 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090  
495 4OKV 1 A, C heavy chain of 8H7 mAb 10090  
496 4OKV 2 B, D light chain of 8H7 mAb 10090  
497 1JGV 1 L Antibody Light Chain 10090  
498 1JGV 2 H Antibody Heavy Chain 10090  
499 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
500 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
501 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090  
502 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
503 2ADF 2 H 82D6A3 IgG FAB 10090  
504 2ADF 3 L 82D6A3 IgG FAB 10090  
505 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090  
506 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090  
507 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544  
508 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544  
509 1UM4 1 L Antibody 21H3 L chain 10090  
510 1UM4 2 H Antibody 21H3 H chain 10090  
511 4RBP 1 K, L Fab 2G12 light chain 9606  
512 4RBP 2 H, M Fab 2G12 heavy chain 9606  
513 3I75 1 A Antibody heavy chain 10090  
514 3I75 2 B Antibody light chain 10090  
515 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606  
516 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606  
517 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606  
518 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606  
519 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606  
520 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
521 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
522 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
523 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090  
524 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090  
525 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090  
526 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090  
527 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
528 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
529 3OAY 1 K, L Fab 2G12, light chain 9606  
530 3OAY 2 H, M Fab 2G12, heavy chain 9606  
531 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090  
532 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090  
533 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
534 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
535 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
536 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
537 4GMT 1 L, M Fab S139/1 light chain 10090  
538 4GMT 2 H, I Fab S139/1 heavy chain 10090  
539 3ZKM 2 C, H FAB HEAVY CHAIN 9606  
540 3ZKM 3 D, L FAB LIGHT CHAIN 10090  
541 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090  
542 1FNS 2 H IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, HEAVY CHAIN 10090  
543 3HNS 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
544 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090  
545 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
546 1KEL 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
547 4DCQ 1 A 3B5H10 FAB Light Chain 10090  
548 4DCQ 2 B 3B5H10 FAB Heavy Chain 10090  
549 3TCL 1 A, H CH04 Heavy Chain Fab 9606  
550 3TCL 2 B, L CH04 Light Chain Fab 9606  
551 3QOT 1 L B3 (IGKV4-1) light chain 9606  
552 3QOT 2 H 1-69 (IGHV1-69) heavy chain FD 9606  
553 4OJF 1 H Humanised 3D6 Fab Heavy Chain 10090  
554 4OJF 2 L Humanised 3D6 Fab Light Chain 10090  
555 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
556 1N0X 2 H, K IMMUNOGLOBULIN HEAVY CHAIN 9606  
557 2FAT 1 L FAB ATN-615, light chain 10090  
558 2FAT 2 H FAB ATN-615, heavy chain 10090  
559 1RUL 1 L immunoglobulin igg2a, light chain fab 10090  
560 1RUL 2 H immunoglobulin igg2a, heavy chain fab 10090  
561 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
562 1T3F 2 B Huzaf antibody heavy chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
563 4H88 2 H POM1 FAB CHAIN H 10090  
564 4H88 3 L POM1 FAB CHAIN L 10090  
565 4X7S 1 H Epididymis luminal protein 214 residues 20-241 9606  
566 4X7S 2 L Ig kappa chain C region residues 23-236 9606  
567 1UM6 1 L antibody 21h3, L chain 10090  
568 1UM6 2 H antibody 21h3, H chain 10090  
569 3H0T 1 A Fab fragment, Light chain 9606  
570 3H0T 2 B Fab fragment, Heavy chain 9606  
571 5A2I 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090  
572 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
573 2AK1 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
574 4X0K 1 A, H Fab fragment heavy chain 9606  
575 4X0K 2 B, L Fab fragment light chain 9606  
576 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
577 1S3K 2 H HU3S193 Fab fragment, heavy chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
578 3HNV 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
579 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090  
580 3LEY 1 H 6a7 Antibody Heavy Chain 10090  
581 3LEY 2 L 6a7 Antibody Light Chain 10090  
582 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090  
583 1YEI 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING DOMAIN 10090  
584 3QPQ 1 C, E, I, L C1068 light chain 10090  
585 3QPQ 2 D, F, H, J C1068 heavy chain 10090  
586 3GJF 4 K, L Antibody light chain 9606  
587 3GJF 5 H, M Antibody heavy chain 9606  
588 3UJJ 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
589 3UJJ 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
590 2HFF 1 A, L CB2 Fab, light chain 9606  
591 2HFF 2 B, H CB2 Fab, heavy chain 9606  
592 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
593 4M7K 2 H 10H10 heavy chain FD, SEE REMARK 999 10090  
594 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090  
595 1NDG 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-8 10090  
596 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090  
597 3OKD 2 B S25-39 Fab (IgG1k) heavy chain 10090  
598 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090  
599 2IPT 2 H IgG2a Fab fragment Light Chain Kappa 10090  
600 1SBS 1 H MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
601 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
602 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
603 1VGE 2 H TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
604 4YDK 2 H HEAVY CHAIN OF ANTIBODY C38-VRC16.01 9606  
605 4YDK 3 L LIGHT CHAIN OF ANTIBODY C38-VRC16.01 9606  
606 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986  
607 4MA3 2 B, H C2095 heavy chain FD, SEE REMARK 999 9986  
608 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090  
609 2FBJ 2 H IGA-KAPPA J539 FAB (HEAVY CHAIN) 10090  
610 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090  
611 1RUQ 2 H immunoglobulin 13G5 heavy chain fab 10090  
612 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090  
613 2HKF 2 H Immunoglobulin Heavy chain Fab fragment 10090  
614 4M6N 1 L CNTO1959 light chain 9606  
615 4M6N 2 H CNTO1959 heavy chain FD 9606  
616 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
617 1YEC 2 H IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
618 3UYP 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
619 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090  
620 6FAB 2 H IGG1-KAPPA 36-71 FAB (HEAVY CHAIN) 10090  
621 3L5X 1 L H2L6 LIGHT CHAIN 9606  
622 3L5X 2 H H2L6 HEAVY CHAIN 9606  
623 2YMX 1 H FAB ANTIBODY HEAVY CHAIN VARIABLE DOMAIN 10090  
624 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
625 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
626 2NXY 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
627 2R8S 2 L Fab light chain 10090  
628 2R8S 3 H Fab heavy chain 10090  
629 4HKZ 1 A Trastuzumab light chain 9606  
630 4HKZ 2 B Trastuzumab heavy chain 9606  
631 3GKZ 1 A anti-methamphetamine single chain Fv 10090  
632 1R3J 1 A Antibody Fab fragment light chain 10090  
633 1R3J 2 B Antibody Fab fragment heavy chain 10090  
634 1MFB 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
635 1MFB 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
636 1RIU 1 L Fab M82G2, Light Chain 10090  
637 1RIU 2 H Fab M82G2, Heavy Chain 10090  
638 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090  
639 3OKK 2 B S25-39 Fab (IgG1k) heavy chain 10090  
640 1MFE 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
641 1MFE 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
642 4M6M 1 L CNTO1959 light chain 9606  
643 4M6M 2 H CNTO1959 heavy chain FD 9606  
644 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090  
645 3BPC 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
646 4OCS 1 L CAP256-VRC26.10 light chain Fab 9606  
647 4OCS 2 H CAP256-VRC26.10 heavy chain Fab 9606  
648 3SO3 2 B A11 FAB light chain 9606  
649 3SO3 3 C A11 FAB heavy chain 9606  
650 2YK1 1 H FAB FRAGMENT, HEAVY CHAIN 9606  
651 2YK1 2 L FAB FRAGMENT, LIGHT CHAIN 9606  
652 4ODT 1 H S1-15 Fab (IgG2b) heavy chain 10090  
653 4ODT 2 L S1-15 Fab (IgG2b kappa) light chain 10090  
654 3IDG 1 A 2F5 Fab light chain 9606  
655 3IDG 2 B 2F5 Fab heavy chain 9606  
656 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
657 2AJX 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
658 3RU8 2 H Antibody b12, Heavy Chain 9606  
659 3RU8 3 L Antibody b12, Light Chain 9606  
660 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
661 1KN2 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
662 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
663 1KN4 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
664 1MFC 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
665 1MFC 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
666 1NQB 1 A, C SINGLE-CHAIN ANTIBODY FRAGMENT VH DOMAIN RESIDUES 2 - 120, VL DOMAIN RESIDUES 121 - 233 10090  
667 2MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
668 3OAU 1 H Fab 2G12, heavy chain Fab 9606  
669 3OAU 2 L Fab 2G12, light chain 9606  
670 2BRR 1 H, Y MN20B9.34 ANTI-P1.4 ANTIBODY, FAB HEAVY CHAIN 10090  
671 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090  
672 1LGV 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
673 3TNN 1 A, C, E, H Fab heavy chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
674 3TNN 2 B, D, F, L Fab light chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
675 3TJE 1 L Fab E09, light chain 9606  
676 3TJE 2 H Fab E09, heavy chain 9606  
677 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090  
678 3HZV 2 B S73-2 Fab (IgG1k) heavy chain 10090  
679 4WY7 1 H Fab 4E10 Heavy chain 9606  
680 4WY7 2 L Fab 4E10Light chain 9606  
681 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
682 1NBZ 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
683 3LS5 1 L Light chain of antibody Fab fragment 10090  
684 3LS5 2 H Heavy chain of antibody Fab fragment 10090  
685 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090  
686 3FO9 2 B, H Immunoglobulin IGG2A - heavy chain heavy chain of 33F12 Fab' fragment 10090  
687 4FZE 1 L N26_i1 Fab light chain 9606  
688 4FZE 2 H N26_i1 Fab heavy chain 9606  
689 1E4W 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
690 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
691 3U0W 1 H Fab Heavy Chain, Ig gamma-1 chain C region chimera of Fab Heavy Chain from mouse, Ig gamma-1 chain C region from human 10090  
692 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090  
693 4JO1 1 L, M monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain Fab 9986  
694 4JO1 2 H, I monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain Fab 9986  
695 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
696 2O5X 2 H chimeric antibody Fab 1E9-DB3 heavy chain 10090  
697 4HIE 1 A Fab 023.102 9606  
698 4HIE 2 B Antibody 023.102 9606  
699 1FL3 1 A, H BLUE FLUORESCENT ANTIBODY (19G2)-HEAVY CHAIN FAB FRAGMENT 10090  
700 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090  
701 4LEX 1 L FAB HEAVY CHAIN 10090  
702 4LEX 2 H FAB LIGHT CHAIN 10090  
703 3QEG 1 H Fab fragment of human anti-HIV antibody N12-i2, heavy chain Fab heavy chain 9606  
704 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
705 3SE9 2 H Heavy chain of antibody VRC-PG04 Antigen binding fragement of heavy chain 9606  
706 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606  
707 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
708 1CE1 2 H PROTEIN (CAMPATH-1H:HEAVY CHAIN) FAB 9606  
709 1Q0Y 1 L Fab 9B1, Light chain 10090  
710 1Q0Y 2 H Fab 9B1, Heavy chain 10090  
711 3EYS 1 L If kappa light chain 10090  
712 3EYS 2 H PFA1 Fab Heavy Chain 10090  
713 3WE6 1 A mAb Fab H fragment 10090  
714 3WE6 2 B mAb Fab L fragment 10090  
715 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
716 12E8 2 H, P IGG1-KAPPA 2E8 FAB (HEAVY CHAIN) FAB FRAGMENT 10090  
717 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
718 1A3R 2 H IGG2A 8F5 FAB (HEAVY CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
719 3ZL4 1 H A17 ANTIBODY FAB FRAGMENT HEAVY CHAIN 9606  
720 3ZL4 2 L A17 ANTIBODY FAB FRAGMENT LAMBDA LIGHT CHAIN 9606  
721 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
722 1HIL 2 B, D IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN) 10090  
723 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
724 2NY2 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
725 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090  
726 1F58 2 H PROTEIN (IGG1 ANTIBODY 58.2 (HEAVY CHAIN)) 10090  
727 1QKZ 2 H ANTIBODY FAB 10090  
728 1QKZ 3 L ANTIBODY FAB 10090  
729 2G60 1 L anti-FLAG M2 Fab light chain 10090  
730 2G60 2 H anti-FLAG M2 Fab heavy chain 10090  
731 4GQP 1 H Anti-METH scFv 10090  
732 4KMT 1 L light chain O12/KAPPA Fab 9606  
733 4KMT 2 H heavy chain 5-51/CNTO888/IGG1 Fab 9606  
734 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090  
735 2FR4 3 B, H antibody heavy chain FAB antigen-binding fragment 10090  
736 4H0H 1 B 2D10 scFv 10090  
737 3NZH 1 L 5F6 LIGHT CHAIN 10090  
738 3NZH 2 H 5F6 HEAVY CHAIN 10090  
739 1RHH 1 A, C Fab X5, light chain 9606  
740 1RHH 2 B, D Fab X5, heavy chain 9606  
741 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090  
742 2Q76 2 B, D Fab F10.6.6 fragment Heavy Chain domain VH and CH1 10090  
743 1TJG 1 L FAB 2F5 Light Chain 9606  
744 1TJG 2 H FAB 2F5 Heavy Chain 9606  
745 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
746 1YEF 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
747 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
748 1YEG 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
749 4LLW 2 B, D light chain Clambda 9606  
750 3IFO 1 A, H 10D5 FAB antibody heavy chain 10090  
751 3IFO 2 B, L 10D5 FAB antibody light chain 10090  
752 1SM3 1 L SM3 ANTIBODY FAB FRAGMENT 10090  
753 1SM3 2 H SM3 ANTIBODY FAB FRAGMENT 10090  
754 4OT1 2 H SM5-1 Fab Heavy Chain 9606  
755 4OT1 3 L SM5-1 Fab Light Chain 9606  
756 4JPI 1 A, H Putative VRC01 germline Fab heavy chain 9606  
757 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
758 4M7J 1 H S25-26 Fab (IgG1k) heavy chain 10090  
759 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090  
760 4XTR 2 C, E Antibody Heavy chain 32630  
761 4XTR 3 D, F Antibody Light chain 32630  
762 1UYW 1 H, M FAB ANTIBODY HEAVY CHAIN 10090  
763 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090  
764 2XQY 2 G, J A13-D6.3 MONOCLONAL ANTIBODY HEAVY CHAIN OF FAB FRAGMENT 10090  
765 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090  
766 3O6K 1 L 11H6H1 Fab' light chain 10090  
767 3O6K 2 H 11H6H1 Fab' heavy chain 10090  
768 3C5S 1 A, C Fab F22-4 light chain 10090  
769 3C5S 2 B, D Fab F22-4 heavy chain 10090  
770 1RZ7 1 L Fab 48d light chain 9606  
771 1RZ7 2 H Fab 48d heavy chain 9606  
772 1RZG 1 A, C Fab 412d light chain 9606  
773 1RZG 2 B, D Fab 412d heavy chain 9606  
774 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090  
775 1GPO 2 H, I ANTIBODY M41 FAB FRAGMENT 10090  
776 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
777 3QOS 2 B, H 3-23 (IGHV3-23) heavy chain FD 9606  
778 2HVK 1 A Antibody Fab heavy chain 10090  
779 2HVK 2 B Antibody Fab light chain 10090  
780 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
781 1MJJ 2 B, H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
782 3PGF 2 H SAB Heavy Chain 9606  
783 3PGF 3 L SAB Light Chain 9606  
784 2QHR 1 H 13F6-1-2 Fab fragment heavy chain 10090  
785 2QHR 2 L 13F6-1-2 Fab fragment V lambda x light chain 10090  
786 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
787 1IQD 2 B HUMAN MONOCLONAL BO2C11 FAB HEAVY CHAIN 9606  
788 1BJM 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN NA/K SO4 9606  
789 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090  
790 1P2C 2 B, E heavy chain VH+CH1 anti-lysozyme antibody F10.6.6 10090  
791 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
792 2NY4 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
793 4NJ9 1 L 8B10 light chain 10090  
794 4NJ9 2 H 8B10 heavy chain 10090  
795 1ORS 1 A 33H1 Fab light chain 10090  
796 1ORS 2 B 33H1 Fab heavy chain 10090  
797 4G6F 1 B, H 10E8 Heavy Chain Fragment of Antigen Binding 9606  
798 4G6F 2 D, L 10E8 Light Chain Fragment of Antigen Binding 9606  
799 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
800 1MLB 2 B IGG1-KAPPA D44.1 FAB (HEAVY CHAIN) 10090  
801 2ZKH 1 L Monoclonal TN1 FAB light chain 9606  
802 2ZKH 2 H Monoclonal TN1 FAB heavy chain 9606  
803 3OJD 1 A Fab V2D2 Light chain 10090  
804 3OJD 2 B Fab V2D2 Heavy chain 10090  
805 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
806 2NY3 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
807 1DCL 1 A, B MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER 9606  
808 3ZKN 2 C, H FAB HEAVY CHAIN 10090  
809 3ZKN 3 D, L FAB LIGHT CHAIN 10090  
810 1LO0 1 L, X If kappa light chain Fab fragment 10090  
811 1LO0 2 H, Y Ig gamma 2a heavy chain 10090  
812 35C8 1 L IGG 5C8 FAB 10090  
813 35C8 2 H IGG 5C8 FAB 10090  
814 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
815 1MIE 2 H IMMUNOGLOBULIN MS5-393 Fab fragment, HEAVY CHAIN 10090  
816 4DVB 1 A, H Fab fragment of pro-uPA antibody mAb-112 10090  
817 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090  
818 2B1H 1 L Fab 2219, light chain light chain 9606  
819 2B1H 2 H Fab 2219, heavy chain heavy chain 9606  
820 3MA9 2 H Fab8066 FAB ANTIBODY FRAGMENT, Heavy Chain 9606  
821 3MA9 3 L Fab8066 FAB ANTIBODY FRAGMENT, Light Chain 9606  
822 1RFD 1 L Fab M82G2, Light Chain 10090  
823 1RFD 2 H Fab M82G2, Heavy Chain 10090  
824 1MFD 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
825 1MFD 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
826 2QQN 2 H Antibody heavy chain 9606  
827 2QQN 3 L Antibody light chain 9606  
828 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090  
829 3RVT 2 D Fab fragment of 4C1 antibody - heavy chain 10090  
830 1JVK 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
831 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
832 3L5W 2 B, H C836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
833 3MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
834 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
835 2NY1 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
836 4OGY 2 H, M DX-2930 HEAVY CHAIN 9606  
837 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
838 3THM 1 L Fab EP6b_B01, light chain 9606  
839 3THM 2 H Fab EP6b_B01, heavy chain 9606  
840 3EOT 1 H FAB FRAGMENT, HEAVY CHAIN 10090  
841 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090  
842 4MA7 2 H POM1 heavy chain Fab 10090  
843 4MA7 3 L POM1 light chain Fab 10090  
844 1LO2 1 L, X If kappa light chain Fab fragment 10090  
845 1LO2 2 H, Y Ig gamma 2a heavy chain 10090  
846 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
847 1UZ6 2 F, H, P, W IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
848 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090  
849 2D03 2 H anti-glycophorin A type N immunoglobulin heavy chain 10090  
850 3UJT 1 H, I Ab-52 heavy chain Fab fragment 10090  
851 3UJT 2 L, M Ab-52 light chain Fab fragment 10090  
852 3O6L 1 L 11H6H1 Fab' light chain 10090  
853 3O6L 2 H 11H6H1 Fab' heavy chain 10090  
854 3E8U 1 H Fab 106.3 heavy chain 10090  
855 3E8U 2 L Fab 106.3 light chain 10090  
856 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
857 1C5B 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
858 4JZN 1 A, C, I Anti-HCV E2 Fab HC84-1 heavy chain 9606  
859 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606  
860 2CMR 2 H D5 9606  
861 2CMR 3 L D5 9606  
862 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090  
863 3GNM 2 H JAA-F11 Fab Antibody Fragment, Heavy Chain 10090  
864 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090  
865 2FD6 3 H H chain of Fab of ATN-615 anti-uPAR antibody 10090  
866 4S2S 1 A, H RoAb13 Fab Heavy chain 10090  
867 4S2S 2 B, L RoAb13 Fab Light chain 10090  
868 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
869 4R4B 2 B, D, F, H FAB 2.2C HEAVY CHAIN 9606  
870 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090  
871 1TET 2 H IGG1 TE33 FAB (HEAVY CHAIN) 10090  
872 4BZ2 2 H FAB 2D73 HEAVY CHAIN 10090  
873 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090  
874 2AEP 2 H FAB heavy chain 10090  
875 2AEP 3 L FAB light chain 10090  
876 4MSW 1 A ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
877 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
878 4FQH 1 A, H antibody CR9114 heavy chain Fab 9606  
879 4FQH 2 B, L antibody CR9114 light chain Fab Lambda 9606  
880 3GRW 2 L Fab light chain 9606  
881 3GRW 3 H Fab heavy chain 9606  
882 4KTD 1 H GE136 Heavy Chain Fab Fab fragment 9544  
883 4KTD 2 L GE136 Light Chain Fab 9544  
884 3LS4 1 L Light chain of antibody Fab fragment 10090  
885 3LS4 2 H Heavy chain of antibody Fab fragment 10090  
886 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
887 1D5I 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
888 4Q2Z 1 A, H Heavy chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
889 4Q2Z 2 B, L Light chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
890 1OSP 1 L FAB 184.1 10090  
891 1OSP 2 H FAB 184.1 10090  
892 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090  
893 1F8T 2 H ANTIBODY FAB FRAGMENT (HEAVY CHAIN) 10090  
894 4LSP 2 H HEAVY CHAIN OF ANTIBODY VRC-CH31 9606  
895 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606  
896 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090  
897 2R2H 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
898 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
899 1DQJ 2 B ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
900 1RIV 1 L Fab M82G2, Light Chain 10090  
901 1RIV 2 H Fab M82G2, Heavy Chain 10090  
902 3QCU 1 H, I LT3015 antibody Fab fragment, heavy chain 9606  
903 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606  
904 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090  
905 1Q9K 2 B S25-2 Fab (IgG1k) heavy chain Heavy Chain g1 10090  
906 4OTX 1 L, M N203 light chain Fab 10090  
907 4OTX 2 H, I N203 heavy chain Fab 10090  
908 4EOW 1 H MB007 human IgG1 Fab fragment heavy chain 9606  
909 4EOW 2 L MB007 IgG1 Fab fragment light chain 9606  
910 1K4C 1 A antibody Fab fragment heavy chain 10090  
911 1K4C 2 B antibody Fab fragment light chain 10090  
912 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
913 2NXZ 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
914 1E4X 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
915 1E4X 2 I TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
916 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
917 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
918 1UJ3 2 B IgG Fab heavy chain anti-tissue-factor antibody hATR-5 Fab 9606  
919 3CLF 1 L Fab light chain 10090  
920 3CLF 2 H Fab heavy chain 10090  
921 4HIX 1 H Humanized 3D6 Fab heavy chain 10090  
922 4HIX 2 L Humanized 3D6 Fab light chain 10090  
923 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
924 4LKC 2 B Fab fragment of PCSK9 antibody 9606  
925 1MHH 1 A, C Fab, light chain 10090  
926 1MHH 2 B, D Fab, heavy chain 10090  
927 4GW5 1 A, C Fab Light Chain 10090  
928 4GW5 2 B, D Fab Heavy Chain 10090  
929 1W72 4 H, I HYB3 HEAVY CHAIN FAB FRAGMENT, RESIDUES 1-211 9606  
930 1W72 5 L, M HYB3 LIGHT CHAIN FAB FRAGMENT, RESIDUES 1-228 9606  
931 4OM1 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
932 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
933 4KZD 1 H BL3-6 Fab antibody, heavy chain 10090  
934 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
935 4HCR 1 H, M PF-547659 heavy chain 9606  
936 4HCR 2 L, N PF-547659 light chain 9606  
937 4CNI 1 A, H OLOKIZUMAB HEAVY CHAIN, FAB PORTION FAB PORTION 9606  
938 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
939 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090  
940 1C1E 2 H CATALYTIC ANTIBODY 1E9 (HEAVY CHAIN) FAB FRAGMENT 10090  
941 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
942 1TJH 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
943 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
944 1YEK 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
945 4HIH 1 A, C Fab 023.102 9606  
946 4HIH 2 B, D Antibody 023.102 9606  
947 3FFD 1 A Monoclonal antibody, heavy chain, Fab fragment 10090  
948 3FFD 2 B Monoclonal antibody, light chain, Fab fragment 10090  
949 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
950 1D6V 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
951 1YY8 1 A, C Cetuximab Fab Light chain 10090  
952 1YY8 2 B, D Cetuximab Fab Heavy chain 10090  
953 1DZB 1 A, B SCFV FRAGMENT 1F9 SEE REMARK 400 10090  
954 4ONG 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
955 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
956 4ETQ 1 A, H anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
957 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090  
958 3QPX 1 L Fab C2507 light chain 10116  
959 3QPX 2 H Fab C2507 heavy chain 10116  
960 3U4E 2 A, H PG9 Heavy Chain 9606  
961 3U4E 3 B, L PG9 Light Chain 9606  
962 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090  
963 2R0Z 2 H IgG2a Fab fragment heavy chain, Fd portion Fd portion of heavy chain 10090  
964 3DRQ 1 A 2F5 Fab' light chain 9606  
965 3DRQ 2 B 2F5 Fab' heavy chain 9606  
966 3NIG 3 E, H Monoclonal antibody 10E5 heavy chain 10090  
967 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090  
968 3UZE 1 A, B Variable domains of murine anti-dengue Mab 4E11 Single chain variable fragment 10090  
969 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
970 1TJI 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
971 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
972 1KEM 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
973 25C8 1 L IGG 5C8 FAB 10090  
974 25C8 2 H IGG 5C8 FAB 10090  
975 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
976 3QNX 2 B Fab fragment of IMMUNOGLOBULIN A1 HEAVY CHAIN 9606  
977 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090  
978 3PHQ 2 B S64-4 Fab (IgG1) heavy chain 10090  
979 3G5V 1 A 806 light chain 10090  
980 3G5V 2 B 808 heavy chain 10090  
981 4OLZ 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
982 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
983 4GSD 1 L H5.3 Fab Light Chain 9606  
984 4GSD 2 H H5.3 Fab Heavy Chain 9606  
985 3UZV 2 B anti-dengue Mab 4E11 Single chain variable fragment 10090  
986 3D0V 1 A 2F5 Fab heavy chain 9606  
987 3D0V 2 B 2F5 Fab light chain 9606  
988 2C1P 1 A, L IGK-C PROTEIN 10090  
989 2C1P 2 B, H IGH-4 PROTEIN FAB-FRAGMENT 10090  
990 3BJL 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN AMMONIUM SULFATE 9606  
991 4O51 1 A, C, E, L QAA-2095-2 light chain 9986  
992 4O51 2 B, D, F, H QAA-2095-2 heavy chain 9986  
993 3S34 1 L 1121B Fab light chain 10090  
994 3S34 2 H 1121B Fab heavy chain 10090  
995 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
996 1GAF 2 H CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
997 2P7T 1 A FAB-A 10090  
998 2P7T 2 B FAB-B 10090  
999 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
1000 3MOD 3 H ANTI-HIV-1 ANTIBODY 2F5 HEAVY CHAIN 9606  
 
Sequence Clusters for the Sequence Entities in PDB 3JWD
Entity #1: Chains: A,B - HIV-1 GP120 ENVELOPE GLYCOPROTEIN protein, length: 379 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 1 1 26908
95% 1 2 17401
90% 1 2 16964
70% 44 69 297
50% 44 69 324
40% 44 69 356
30% 44 69 359
Entity #2: Chains: C,D - T-cell surface glycoprotein CD4 protein, length: 184 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 17 30 865
95% 20 35 982
90% 20 35 1003
70% 20 35 1034
50% 20 35 1076
40% 20 35 1096
30% 20 35 1073
Entity #3: Chains: L,O - FAB 48D LIGHT CHAIN protein, length: 213 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 4 12033
95% 43 116 81
90% 223 414 4
70% 781 1404 3
50% 1874 3339 1
40% 1875 3340 1
30% 2123 3953 1
Entity #4: Chains: H,P - FAB 48D HEAVY CHAIN protein, length: 220 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 4 11989
95% 2 4 11418
90% 2 4 11243
70% 912 1614 2
50% 1875 3339 1
40% 1876 3340 1
30% 2124 3953 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.